GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (BOM:532523) » Definitions » Gross Margin %

Biocon (BOM:532523) Gross Margin % : 65.29% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Biocon Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Biocon's Gross Profit for the three months ended in Dec. 2023 was ₹23,169 Mil. Biocon's Revenue for the three months ended in Dec. 2023 was ₹35,487 Mil. Therefore, Biocon's Gross Margin % for the quarter that ended in Dec. 2023 was 65.29%.


The historical rank and industry rank for Biocon's Gross Margin % or its related term are showing as below:

BOM:532523' s Gross Margin % Range Over the Past 10 Years
Min: 58.31   Med: 63.52   Max: 67.96
Current: 66.06


During the past 13 years, the highest Gross Margin % of Biocon was 67.96%. The lowest was 58.31%. And the median was 63.52%.

BOM:532523's Gross Margin % is ranked better than
56.17% of 746 companies
in the Biotechnology industry
Industry Median: 59.74 vs BOM:532523: 66.06

Biocon had a gross margin of 65.29% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Biocon was 2.00% per year.


Biocon Gross Margin % Historical Data

The historical data trend for Biocon's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocon Gross Margin % Chart

Biocon Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.71 67.59 67.96 66.06 66.46

Biocon Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.81 66.80 64.66 67.45 65.29

Competitive Comparison of Biocon's Gross Margin %

For the Biotechnology subindustry, Biocon's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biocon's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biocon's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Biocon's Gross Margin % falls into.



Biocon Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Biocon's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=72673 / 109341
=(Revenue - Cost of Goods Sold) / Revenue
=(109341 - 36668) / 109341
=66.46 %

Biocon's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=23169 / 35487
=(Revenue - Cost of Goods Sold) / Revenue
=(35487 - 12318) / 35487
=65.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Biocon  (BOM:532523) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Biocon had a gross margin of 65.29% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Biocon Gross Margin % Related Terms

Thank you for viewing the detailed overview of Biocon's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocon (BOM:532523) Business Description

Traded in Other Exchanges
Address
20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560 100
Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Generics, Biosimilars, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene.

Biocon (BOM:532523) Headlines

No Headlines